FDA Investigator Craig A Garmendia

Craig A Garmendia has inspections in 24 countries as of 08 Dec 2023. Craig A Garmendia has collaborated with a combinined 3886 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
208
Last Inspection Date:
08 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Germany, Poland, Japan, Australia, United Kingdom of Great Britain and Northern Ireland, Canada, New Zealand, Austria, France, Italy, Denmark, Georgia, Czechia, Spain, South Africa, Argentina, Thailand, Moldova (Republic of), Ukraine, Belize, Hungary
Co-Investigator(s):
Aaron F Coleman, Adam M Derr, Ademola O Daramola, Alanna Lmussawwir Bias, Albert A Salvador, Allen F Hall, Amanda E Lewin, PhD, Ana Delp Cintron, Ana P Barido, Andrea A Branche, Annette Melendez, Anthony J Grace, Arindam Dasgupta, PhD, Barbara A Rusin, Barbara D Wright, Barbara M Frazier, Benita C Okeke, Betsy C Galliher, Bill Tacket, Jr, Bonita S Chester, Brooke K Higgins, Brunilda Torres, Byungja E Marciante, Cara L Alfaro, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chiaochun J Wang, Christos G Tsingelis, Clara E Santiago, Clotia Cabbey Mensah, Colleen M Aspinwall, Courtney A Gilbert, Courtney A Hunt, Craig T Rybus, Dandan Wang, PhD, Daniel J Roberts, Daniel L Aisen, David R Heiar, Dawn C Olenjack, Dawn M Mccabe, Dawne M Hines, Dennis R Hock, Devaughn Edwards, Dianiris C Ayala, Dianne H Milazzo, Don A Leeseberg, Douglas Florentino, Dr. Gopa Biswas, PhD, Dr. Sriram Subramaniam, PhD, Dyvette Arline, Eduardo Carbonell, Edwards, Edwin J Gorney, Emily A Baldwin, Emir Galevi, Ethan P Stegman, Fabian Nchaparro Rodriguez, Farhana Khan, Figarole, Gabriel E Muniz, Gajendiran Mahadevan, PhD, Gene R Gunn, George C Amedro, Gerald N Mcgirl, DDS, German Rivera, Gisselle I Sensebe, Gulshan R Anand, Hasan A Irier, PhD, Heather M Bullock, Hecter Jcolon Torres, Hector J Colon Torres, Himanshu Gupta, PhD, James E Frye, James M Kewley, James P Mcevoy, James To Neal, Jana L Caylor, Janete F Guardia, Jean M Mulinde, MD, Jeanne J Thai, Jennifer Adams, MPH, Jennifer C Adams, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer L Sheehan, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Joann Walters Salvatierra, Joanne E King, Jogy George, John A Kadavil, PhD, Jonee J Mearns, Jose Acruz Gonzalez, Ka L Wong, Kara A Scheibner, PhD, Karen M Cooper, Karen M Rodriguez, Karl D Hezel, Katherine M Taylor, Kathleen V Ferguson, Kathryn A Krentz, Kelly M Byers, Ladislav Kermet, Lakecha N Lewis, Larry K Austin, Laura E Garcia, Lawrence Y Lee, PhD, LCDR Angelica M Chica, LCDR Randall L Morris, Leo J Lagrotte, Leslie A Jackanicz, Li Hongpaul Yeh, PhD, Libia M Lugo, Liming Zhang, Linda K Matheny, Linda R Kuchenthal, Lisa P Oakes, Lori A Gioia, Lt Bill Tackett, Jr, LT Richard A Lyght, Luz I Collado, Makini Cobourne Duval, PhD, Marc Balzarini, Margaret Torres Vazquez, Maria V Price, Mark V Preciados, Martin K Yau, PhD, Matthew C Watson, Matthew F Duff, Melkamu Getie Kebtie, PhD, Mendoza, Michael C Lombardi, Michael P Anthony, Michael Serrano, Michelle D Haamid, Michelle M Noe, Michelle M Noe Varga, Miguel A Martinez, Minh D Phan, Mizanne E Lewis, Mohsen Rajabi Abhari, FDA, Mra Mcculloughj, Nancy A Bellamy, Nicola M Fenty Stewart, Nicolas Riveratorres, Nicole E Knowlton, Nicole M Bell, Nilufer Tampal, PhD, Omayra Nrodriguez Ruiz, Ormond, Paul L Figarole, Jr, Paula M Laplant, Perry H Gambrell, Rachel A Peters, Ramon H Pabon Aponte, Randy L Clarida, Raymond A Lyn, Jr, Rebecca Rodriguez, Rebecca T Davis, Richard K Vogel, Richard W Berning, Rina Bhikha, Robert D Tollefsen, Roy R Rinc, Ruben C Ayala, PharmD, Ruth A Williams, Samantha J Pinizzotto, D V M, Sandra S Saniga, Sarah E Mcmullen, Saundrea A Munroe, Scott B Laufenberg, Seongeun Cho (Julia), PhD, Sereen Gmorgan Murray, Sharon Giamberini, Sharon L Matson, Sherbet L Samuels, Sheri L Stephenson, Sonia M Monges, Sripal R Mada, PhD, Stacey L Witherwax, Stanley B Eugene, BS, BME, State Agency, Stephanie D Crockett, Stuart W Russell, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan M Corrales, Susan M Turcovski, Suzanne N Vallez, Tawny L Colling, Teresa I Navas, Thea C Grome, Thomas J Arista, Thomas W Nojek, Timothy C Grome, Tina A Desorcy, Torrance J Slayton, Tracey L Harris, Traci M Armand, Vanessa E Coulter, Victor Spanioli, Virginia L Meeks, Viviana Matta, Walden H Lee, William P Tonkins, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD, Young M Choi, PhD, Yumi J Hiramine, Zerita White

Craig A Garmendia's Documents

Publish Date Document Type Title
May, 2016 FDA 483 Martin Valdes, M.D. - Form 483, 2016-05-05
August, 2022 FDA 483 Thatthan Suksombooncharoen, MD - Form 483, 2022-08-26
August, 2021 FDA 483 Marc C. Gittelman, M.D. - Form 483, 2021-08-26
April, 2017 FDA 483 Yvelice Villaman-Bencosme - Form 483, 2017-05-02
November, 2013 FDA 483 Weiner, Gilbert R. - Form 483, 2013-11-25
September, 2009 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2009-09-04
November, 2013 EIR Weiner, Gilbert R. - EIR, 2013-11-25
April, 2015 EIR Gilbert R. Weiner, DO - EIR, 2015-04-30
August, 2017 FDA 483 Hector S. Rodriguez, MD - Form 483, 2017-08-10
May, 2015 FDA 483 Mark E. Kutner, M.D. - Form 483, 2015-05-15
April, 2023 FDA 483 Jacek Mackiewicz, MD, PhD - Form 483, 2023-04-28
March, 2012 FDA 483 Zachary K. Segal, M.D. - Form 483, 2012-03-02
January, 2018 FDA 483 Shevanti M. Jegasothy, MD - Form 483, 2018-01-19
April, 2013 EIR David H. Flaherty - EIR, 2013-04-01
October, 2014 FDA 483 Marquez, Farid - Form 483, 2014-10-06
May, 2013 EIR Ana J. Fandino - EIR, 2013-05-22
May, 2015 FDA 483 Mark E. Kutner, MD - Form 483, 2015-05-15
October, 2018 FDA 483 Raimundo J. Acosta, MD - Form 483, 2018-10-02
September, 2010 EIR Lex Inc - EIR, 2010-09-28
October, 2014 FDA 483 Response Marquez, Farid - Form 483R, 2014-10-23
May, 2013 FDA 483 Response Ana J. Fandino - Form 483R, 2013-06-03
March, 2013 EIR WIL Research - EIR, 2013-03-07
March, 2013 FDA 483 WIL Research - Form 483, 2013-03-07
August, 2018 FDA 483 Celestino P. Castellon, MD - Form 483, 2018-08-30
November, 2013 FDA 483 Response Weiner, Gilbert R. - Form 483R, 2013-12-03
May, 2015 EIR Mark E. Kutner, MD - EIR, 2015-05-15
August, 2021 EIR Marc C. Gittelman, M.D. - EIR, 2021-08-26
April, 2013 FDA 483 David H. Flaherty - Form 483, 2013-03-20
April, 2015 FDA 483 Gilbert R. Weiner, DO - Form 483, 2015-04-30
March, 2013 EIR Research Triangle Institute - EIR, 2013-03-06
May, 2013 FDA 483 Ana J. Fandino - Form 483, 2013-05-22
May, 2021 FDA 483 Joseph A. Zadra, MD - Form 483, 2021-05-07
December, 2011 FDA 483 Phase One Solutions, Inc. - Form 483, 2011-12-01
June, 2019 EIR ICS Arensia Exploratory Medicine SRL - EIR, 2019-06-20
May, 2021 FDA 483 Joseph A. Zadra, MD - Form 483, 2021-05-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more